Piyush Goyal Pharma Patent Criticism: Goyal Criticises Pharma Patent Extensions Over Minor Modifications
Piyush Goyal pharma patent criticism: Commerce and Industry Minister Piyush Goyal has raised concerns about pharmaceutical companies seeking extended patent protection through minor modifications to existing drugs. Speaking at a recent event, Goyal warned that such practices could hinder access to affordable medicines worldwide. He emphasised that prioritising excessive profits for a few companies and their shareholders should not come at the expense of providing equitable, quality healthcare for all.
India’s Stance on Patent Laws and Public Health: Against Evergreening Practices
Goyal also criticised the practice of evergreening, where pharmaceutical firms make slight changes, such as new mixtures or formulations, to existing drugs in order to extend patent protection. India’s patent laws, particularly Section 3d of the Indian Patents Act, 1970, place strict restrictions on granting patents for known drugs unless there is a significant improvement in efficacy. Similarly, Section 3b prevents patents for products that could harm public interest without offering enhanced benefits. While multinational companies have pushed for changes to India’s patent regulations, the country has steadfastly resisted amending its laws.
Healthcare Access and Sustainable Development: A Core Focus for India
During his address, Goyal highlighted the critical connection between access to affordable healthcare and sustainable development. He commended India’s progress in expanding healthcare services and stressed that ensuring access to essential medicines is crucial for equitable healthcare distribution. According to Goyal, affordable healthcare is vital not only for individual well-being but also for broader goals of inclusive social growth.
India’s Commitment to Protect Public Health Over Patent Pressures
Goyal’s remarks reaffirmed India’s commitment to protecting public health by maintaining strict patent regulations. He reiterated that India would not succumb to international pressures aimed at weakening its patent laws. By prioritising patient welfare over corporate profits, India aims to create a healthcare system that benefits all citizens, ensuring broader access to essential medicines.
For those dealing with the complexities of patent laws and seeking guidance on healthcare regulations, our expert team at Vakilsearch offers legal advice to ensure compliance with India’s stringent patent frameworks. Protect your innovations while keeping public health priorities in mind. Reach out to us for guidance on patent law and healthcare-related matters.
- Two arrested for Rs 4.2 crore GST fraud in Gujarat - May 12, 2025
- Samsung $520 million tax demand challenged in India by Samsung. - May 6, 2025
- FSSAI Defends Ban on ‘100% Fruit Juice’ Claims in Court - May 2, 2025
